Search API
Bamlanivimab is a recombinant, neutralizing human IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS-CoV-2
March 5, 2021
COVID-19 Oxygen Emergency Task Force brings access to Africa
February 25, 2021
Long COVID referred to as Post-Acute Sequelae of SARS-CoV-2 infection
February 24, 2021
COVAX global access to COVID-19 vaccines includes no fault compensation fund
February 23, 2021
Janet Woodcock M.D. confirms the safety of the U.S. food supply
February 18, 2021
SARS-CoV-2 is like other RNA viruses changing through mutation with new variants occurring
February 18, 2021
COVID-19 vaccine effectiveness monitoring is coordinated by the Center for Biologics Evaluation and Research
February 14, 2021
Prophylactic anticoagulation treatment reduced coronavirus disease 2019 mortality
February 13, 2021
Rockefeller monoclonal antibodies are highly potent in blocking the SARS-CoV-2 spike protein and neutralizing the coronavirus
February 3, 2021
Innovative vaccine technology could protect against coronavirus strains with a single vaccination
February 2, 2021
